Long term safety and efficacy of the Yukon Choice Flex sirolimus-eluting coronary stent-a real-world data from India

Indian Heart J. Nov-Dec 2021;73(6):733-736. doi: 10.1016/j.ihj.2021.09.006. Epub 2021 Sep 10.

Abstract

In-stent restenosis and stent thrombosis are the major concerns while choosing a coronary stent. This single-centre, retrospective study evaluated the one and three-year clinical outcomes following implantation of Yukon Choice Flex (YCF) sirolimus-eluting stent. A total of 168 consecutive patients with 217 lesions underwent stenting with YCF stent. The presentation was with acute coronary syndrome in 158 (94%) patients. At 3 years, 9 (5.3%) patients died due to cardiac cause. Myocardial infarction, and definite stent thrombosis occurred in 10 (6%) and 4 (2.4%) patients respectively. Redo stenting and coronary artery bypass surgery was performed in 3 (1.8%) and 1 (0.6%) patient respectively. The use of YCF sirolimus eluting stent was associated with a favourable safety and efficacy profile at one and three-years of follow-up in a high-risk population.

Keywords: Drug-eluting stent; In-stent restenosis; Stent thrombosis; Yukon choice flex.

MeSH terms

  • Coronary Angiography
  • Coronary Restenosis* / diagnosis
  • Coronary Restenosis* / epidemiology
  • Drug-Eluting Stents*
  • Humans
  • India / epidemiology
  • Retrospective Studies
  • Sirolimus
  • Treatment Outcome
  • Yukon Territory

Substances

  • Sirolimus